Silo Pharma
SILO
16 hedge funds and large institutions have $168K invested in Silo Pharma in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
33% more funds holding
Funds holding: 12 → 16 (+4)
3.54% less ownership
Funds ownership: 7.8% → 4.26% (-3.5%)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
71% less capital inflows, than outflows
Capital inflows: $66.8K | Capital outflows: $231K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$20.7K |
| 2 |
XTX Topco
George Town,
Cayman Islands
|
+$15K |
| 3 |
HRT Financial
New York
|
+$11.8K |
| 4 |
Two Sigma Securities
New York
|
+$11.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$195K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$15.8K |
| 3 |
Virtu Financial
New York
|
-$15.7K |
| 4 |
BWM
Bullock Wealth Management
Bloomington,
Indiana
|
-$4.49K |
| 5 |
Lazard Asset Management
New York
|
-$62 |
SILO Hedge Fund Activity: Q4 2024 in Review
16 of the 7,624 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q4 2024, worth a combined $168K — down 56% from $383K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SILO positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 4 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $20.7K. The largest seller was Renaissance Technologies, cutting an estimated $195K.
- 16 institutional investors held Silo Pharma (SILO) as of Q4 2024, up from 12 in Q3 2024.
- Funds reported $168K of Silo Pharma stock for Q4 2024, down 56% quarter-over-quarter.
- 5 funds opened new Silo Pharma positions in Q4 2024 and 1 closed out, a net change of +4 holders.
- The largest Silo Pharma buyer in Q4 2024 was UBS Group, an estimated $20.7K added.
- The largest Silo Pharma seller in Q4 2024 was Renaissance Technologies, an estimated $195K sold.
Based on aggregated 13F filings for Q4 2024.